期刊文献+

格瑞林对慢性心力衰竭大鼠心肌组织中细胞凋亡信号调节激酶1表达的影响 被引量:6

The effect of the expression of ASK1 of Ghrelin in myocardial rats with CHF
下载PDF
导出
摘要 目的:探讨格瑞林对CHF大鼠心肌组织中ASK1表达的影响。方法:采用结扎左冠状动脉前降支建立大鼠CHF模型,通过HE染色观察大鼠心肌细胞形态变化,免疫组织化学观测ASK1在大鼠心肌组织中表达的变化。结果:CHF模型治疗组心肌损伤较CHF模型组明显减轻,差于假手术对照组;CHF模型治疗组ASK1阳性表达区面积与总面积之比低于CHF模型组(P<0.05),高于假手术对照组(P<0.01)。结论:格瑞林可抑制心肌组织中ASK1的表达,改善心功能,抑制心肌重塑,延缓CHF的进程。 Objective:To probe into the effect of the expression of ASK1 of Ghrelin in myocardial rats with CHF. Methods:The CHF group was prepared by ligaturing left anterior descending coronary arterying ilur of hear, to observe, through HE staining, the morphological change of the myocardial cells of rats, and to ob- serve, through immunohistochemieal method, the change of expression of ASK1 in the myocardial cells. Re- suits:Compared with CHF group, the myocardial injury of CHF treatment group was alleviated obviously, but worse than Sham--operation control group; The ratio of the CHF treatment group between the area of positive expression of ASK1 with total area is below CHF group (P〈0.05), but above Sham--operation control group (P〈 0.01). Conclusion:Ghrelin can inhibit the expression of ASK1 in myocardial cells, improve cardiac func- tion, restrain myocardial remodefing, and postpone the process of CHF.
出处 《黑龙江医药科学》 2012年第3期9-11,共3页 Heilongjiang Medicine and Pharmacy
基金 佳木斯大学研究生创新科研基金项目 编号:YJSCX2011-010JD
关键词 格瑞林 心力衰竭 凋亡信号调节激酶1 Ghrelin chronic heart failure ASK1
  • 相关文献

参考文献10

  • 1郭畅,刘文娴.心力衰竭的流行病学与防治现状[J].中国健康教育,2010,26(2):139-141. 被引量:53
  • 2王维亭,赵专友,汤立达.心衰治疗靶点与干预研究进展[J].中国新药杂志,2010,19(6):486-493. 被引量:11
  • 3Leong D P. De Pasqluale C G, Selvanayagam J B. Heart failure with normal ejection fraction: the complementary roles of echocar- diogrraphy and CMR imaging [J]. JACC Cardiovasc Imaging, 2010. 3(4) :409-420.
  • 4Paulus W j,Van Ballegoij J J. Treatment of heart failure with nor- mal ejection fraction: an inconvenient truth[J]. J Am Coil Cardiol. 2010, 55(6):526-537.
  • 5Kashiwase K, Higuchi Y, Hirotani S, et al. CaMKII activates ASKland NF-kappaB toinduce eardiomycyte hypertrophy [J]. Biochem Biophys Res Commun, 2005, 327(1):136-142.
  • 6Pfeffer M A,Pfeffer J M,Fishbein M C,et al. Myocardial infarct size and ventricular function in rats[J]. Cire Res. 1979,44: 503- 512.
  • 7欧叶涛,扈清云,李梅秀,王培军,田国忠.慢性心力衰竭时心肌组织中CGRP的含量变化及mRNA表达[J].解剖学研究,2006,28(1):38-40. 被引量:7
  • 8赵勇,田国忠,李梅秀,欧叶涛,孙权,尹兴忠.IL-6在心衰大鼠心肌组织中表达及GHRP的干预作用[J].黑龙江医药科学,2011,34(4):31-32. 被引量:6
  • 9陈乃蜂.GHRP对慢性心衰大鼠心肌中JNKl表达的影响[M].佳木斯大学.2011.
  • 10Luyendyk J P,PiPer J D. A Novel class of antioxidants inhibition LPS induvction of tissue factor by selective inhibition of activation of ASK1 and MAP kinam[J]. Arterioseler Thrornb Vase Biol. 2007, 27(8):1857-1862.

二级参考文献78

  • 1欧叶涛,田国忠,李梅秀,付纯芳.慢性心衰大鼠心脏CGRP免疫阳性细胞的形态与分布[J].解剖学研究,2005,27(4):268-270. 被引量:1
  • 2Gheorghiade M, Bonow RO. Chronic heart failure in the United States: amani festation of coronary artery disease [ J ]. Circulation, 1998, 97(3) :282 -289.
  • 3ACC/AHA. Guidelines for the evaluation and management of chronicheart failure[ J]. Circulation ,2001,104:2996 - 3007.
  • 4AHA 2002 heart and stroke statistical update[ M ]. Dallas:American Heart Association,2001.1.
  • 5Cohen-Solal. Guidelines for the diagnosis and treatment of chronic heart failure: task force for the diagnosis and treatment of chronic heart failure [ J ]. Eur Heart J,2001,22 : 1527 - 1560.
  • 6顾东风,黄广勇,江河,等.中国心力衰竭流行病学调查及患病率--中国心血管健康多中心合作研究[C].北京:第七次全国心血管病学术会议,2002,7.
  • 7Corwie MR, Wood DA, Coats JS, et al. Incidence and aetiology of heart failure : a population-based study [ J ]. Eur Heart J, 1999,20 : 421 - 428.
  • 8Ho KK, Pinsky JL, Kannel WB, et at. The epidemiology of heart failure: the Framingham Study[ J]. J Am Coll Cardiol, 1993,22 (Suppl A) :6A- 13A.
  • 9GUSTO. Comparison of four therapeutic strategies in acute myocardial infarction [ J ]. Internist ( Berl), 1993,34 ( Suppl 7 ) : 1 - 12.
  • 10Topoi EJ. Validation of the early open infarct vessel hypothesis [ J ]. Am J Cardiol, 1993,72:40G -45G.

共引文献71

同被引文献49

  • 1李晓东,孙亚清,杨智勇,曹乾.氯沙坦对心力衰竭患者肿瘤坏死因子α和血管内皮依赖性舒张功能的影响[J].中华心血管病杂志,2004,32(6):519-521. 被引量:7
  • 2张海英,陆春风,张兰英,王立波.慢性心力衰竭患者血清sVCAM-1及TNF-α的测定与临床意义[J].黑龙江医药科学,2006,29(1):26-27. 被引量:4
  • 3Verrecchia F,Mauviel A.Transforming grmth factor beta and fibmeis[J].World Gastroenterology,2007,13(22):3056.
  • 4Yamaoka M,Tojo T,Inomata T,etal.Circulating levels of interleukin 18 reflect eologies of heart failure:Th1/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failure[J].J Card Fail,2002,8:21.
  • 5Mallat Z,Heymes C,Corb A,et al.Evidence for altered interleukin (IL)218 pathway in human heart failure[J].FASEB J,2004,18:752.
  • 6Sugamori T,Ishibashi Y.Inmmed nitric oxide in proportion to the severity of heart failure in patients with dilated cardiomyopathy:cloee conelation of tumor necrosis factor-alpha with systemic and local pmduon of nitric oxide[J].Circ J,2002,66:627-632.
  • 7Nagaya N,Miyatake K,Uematsu M,et al.Hemodynamic,renal,and hormonal effects of ghrelin infusion in patients with chronic heart failure[J].J Clin Endocrinol Metab,2001,86(12):5854-5859.
  • 8Nagaya N,Kangawa K.Therapeutic potential of ghrelin in the treatment of heart failure[J].Drugs,2006,66(4):439-448.
  • 9Nagaya N,Kojima M,Uematsu M,et al.Hemodynamic and hormonal effects of human ghrelin in healthy volunteers[J].Am J Physiol Regul Integr Comp Physiol,2001,280(5):1483-1487.
  • 10Nagaya N,Kangawa K.Ghrelin,a novel growth hormonereleasing petide,in the treatment of chronic heart failure[J].Regul Pept,2003,114(2-3):71-77.

引证文献6

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部